Help! Please Register



  The Fungi

  Image Bank
  Lecture Bank
  Video Bank




  MIC Database

  Education &

  Good Books
  Events Calendar

  About Us

  Our Mission
  Editorial Board
  Editorial Staff
  Legal Stuff
  Privacy Policy

  The Fungi

  Image Bank
  Lecture Bank
  Video Bank

This page updated:
1/27/2007 9:23:00 AM

DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy

Site built and designed for doctorfungus by Webillustrated

You are here: Education & Tools >
Merck & Co., Inc.
Course and Test - take it your way
Start CME

Course Title:
Advancing the Art of Antifungal Therapy:
New therapeutic options and treatment strategies

Target Audience:

This activity will be of relevance to hematologists, oncologists, critical care specialists and infectious disease specialists. In addition, this program will provide useful information and guidance to all medical professionals who should be aware of the latest developments in fungal infections.


Activity description:

Welcome to this exciting CME-accredited activity "Advancing the Art of Antifungal Therapy: New therapeutic options and treatment strategies".

There has recently been an increase in both the choice of treatment options and available clinical information for the treatment of systemic fungal infections. This wide range of information can prove to be overwhelming for the physician who must select the best treatment strategy for their patients. This webcast will review available clinical data in support of various treatment options and approaches in order to provide clear guidance to physicians.

Learning objectives:

On completion of this activity, the participant should be able to:
  • Review the epidemiology of fungal infections in immunosuppressed patients
  • Compare the different treatment approaches to fungal infections
  • Discuss the clinical indications for each treatment approach
  • Analyze the latest clinical data on therapeutic options
  • Evaluate the optimal treatment strategy for their individual patients.

Faculty and disclosure statement:

Thomas F. Patterson, MD, FACP
Professor of Medicine
The University of Texas Health Science Center at San Antonio
San Antonio, TX

CME Consultants, Inc. holds the standard that its continuing medical education activities be free of commercial bias.

Now, in accordance with the disclosure policy of CME Consultants, Inc., as well as standards set forth by the ACCME, the ANCC and the ACPE, faculty have been asked to disclose any relationship they have to companies producing pharmaceuticals, medical equipment, prostheses, etc. that might be germane to the content of their lectures and any relationship they have with the commercial supporter(s) of the activity. Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide registrants with information that might be of potential importance to their evaluation of a given talk. The faculty is also aware it is their responsibility to inform the audience if discussion of any non-FDA approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.

Faculty have reported receiving something of value* from a company whose product may be germane to the content of their presentations.

Thomas F. Patterson
BMS, Fujisawa, Merck, Microbia, Pfizer, Schering-Plough, Uriach Versicor

Grant support

Fujisawa, Merck, Pfizer, Schering-Plough
Speaker bureau

Merck, Pfizer

* "Something of value" refers to an equity position, vested interest, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for education services elsewhere, or to any other relationship to a company that provides suffi cient reason for disclosure, in keeping with the spirit of the stated policy.


CME Consultants, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Consultants, Inc. designates this educational activity for a maximum of 1 (one) category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Date of original release: August 2004

Valid for CME credit through August 31, 2005


This CME is supported by an unrestricted educational grant from
    Merck and Co., Inc.
Program Organizer:

Privacy Policy
Site Contents Copyright © 2007


  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us